Skip to Main Content

Paper Details

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease.
Neurology
131
2014
AD, ADAS, Alzheimer disease, Alzheimer's Disease, CONCLUSIONS, PF-04494700, RAGE, RAGE-A, cognitive decline, confusion, patients, receptor for advanced glycation end products
Author NameAffiliation
Douglas GalaskoUniversity of California, MA Banner Sun Health Research Institute (M.N.S.), Sun City University of Arizona (M.N.S.), Yale University
  • 1 - 1

Datasets

Release 1.2